US Stock MarketDetailed Quotes

SMMT Summit Therapeutics

Watchlist
  • 4.390
  • +0.330+8.13%
Close May 3 16:00 ET
  • 4.410
  • +0.020+0.46%
Post 18:47 ET
3.08BMarket Cap11.55P/E (TTM)

Summit Therapeutics Key Stats

Summit Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 1, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.06

+95.80%

Buy

Mar 25, 2024

Summit Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 1, 20242024/Q10.000 / 0.000--
--2021/Q3975.890K / 0.000--
--2021/Q24.455M / 3.192M--
--2021/Q15.641M / 3.160M--
Dec 17, 20192020/Q33.896M / 3.611M--
Oct 11, 20192020/Q24.261M / 3.972M--
Jun 12, 20192020/Q15.120M / 3.734M--
Mar 27, 20192019/Q42.469M / 2.454M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 1, 20242024/Q10.000 / 0.000--
--2021/Q3975.890K / 0.000--
--2021/Q24.455M / 3.192M--
--2021/Q15.641M / 3.160M--
Dec 17, 20192020/Q33.896M / 3.611M--
Oct 11, 20192020/Q24.261M / 3.972M--
Jun 12, 20192020/Q15.120M / 3.734M--
Mar 27, 20192019/Q42.469M / 2.454M--

Unlock Free Earnings Estimates

Summit Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 25, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg